Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Serocki M, Bartoszewska S, Janaszak-Jasiecka A, Ochocka RJ, Collawn JF, Bartoszewski R
In the SUSTAIN-6 trial, semaglutide was associated with a significant increased risk of diabetic retinopathy complications, including vitreous hemorrhage, blindness, or conditions requiring treatment with an intravitreal agent or photocoagulation (HR 1.76, 95% CI 1.112.78) [27]
Four-year follow-up of weight loss maintenance using electronic medical record data: the PROPEL trial
Ceftriaxone- and N-acetylcysteine-induced brain tolerance to ischemia: influence on glutamate levels in focal cerebral ischemia
US$ 27.12
US$ 26.39
US$ 28.21
US$ 23.34
US$ 29.58
US$ 20.35
US$ 27.90
US$ 20.66
US$ 22.34
US$ 22.70
US$ 20.16
US$ 22.67
